Previous chapter:
Chapter 191 Patent infringement?
Next chapter:
Chapter 193 Technical self-confidence
PREVIEW
... tment, which not only violated the international clinical trial rules for the treatment of malignant tumors, but also violated Xia Guo's own rules for clinical experiments. We have reason to suspect that Pangu Technology ’s clinical trials are simply a procedure, and we have reason to suspect that Pangu Technology ’s technology came from the United States.
"New York Times": The New York court accepted Bristol-Myers Squibb's infringement on Pangu Technology's gene expression therapy infrin ...
YOU MAY ALSO LIKE

























